title: Engineered CRISPR/Cas13d Virus-Like Particles for Potent, Safe Gene Therapy of Idiopathic Pulmonary Fibrosis
design: Mouse were administered PBS via tracheal injection, starting on day 7 they received tracheal PBS injections every two days for a total of four injections. Lung tissues were collected for sequencing, and the samples were divided into three parts  for sequencing.